Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders

Aim: L -3,4-dihydroxy-6–18F-fluorophenylalanine (18F-DOPA PET may be used to distinguish subjects with Parkinsonism from those with symptoms not originating from impaired dopaminergic transmission. However, it is not routinely utilized to discriminate Idiopathic Parkinson's disease (IPD) from A...

ver descrição completa

Detalhes bibliográficos
Main Authors: Gilles N. Stormezand, Lumi T. Chaves, David Vállez García, Janine Doorduin, Bauke M. De Jong, Klaus L. Leenders, Berry P.H. Kremer, Rudi A.J.O. Dierckx
Formato: Artigo
Idioma:English
Publicado em: Elsevier 2020-01-01
Colecção:NeuroImage: Clinical
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2213158219305078
_version_ 1831615195185676288
author Gilles N. Stormezand
Lumi T. Chaves
David Vállez García
Janine Doorduin
Bauke M. De Jong
Klaus L. Leenders
Berry P.H. Kremer
Rudi A.J.O. Dierckx
author_facet Gilles N. Stormezand
Lumi T. Chaves
David Vállez García
Janine Doorduin
Bauke M. De Jong
Klaus L. Leenders
Berry P.H. Kremer
Rudi A.J.O. Dierckx
author_sort Gilles N. Stormezand
collection DOAJ
description Aim: L -3,4-dihydroxy-6–18F-fluorophenylalanine (18F-DOPA PET may be used to distinguish subjects with Parkinsonism from those with symptoms not originating from impaired dopaminergic transmission. However, it is not routinely utilized to discriminate Idiopathic Parkinson's disease (IPD) from Atypical Parkinsonian Disorders (APD). We investigated the potential of FDOPA PET to discriminate between IPD and APD, with a focus on the anterior-to-posterior decline in het striatum, considered to be more specific for IPD. Materials and methods: 18F-DOPA PET data from a total of 58 subjects were retrospectively analyzed. 28 subjects had idiopathic Parkinson's disease (14 male, 14 female; age at scan 61 +- 11,5), 13 atypical Parkinsonian disease (7 male, 6 females; age at scan: 69,6 +- 6,4) and 17 were controls (6 male, 11 female; age at scan 65,3 +-8,6). Regional striatal-to-occipital ratio's (RSOR's) were calculated, as well as multiple in-line VOI's from the caudate nucleus to the posterior part of the putamen. The linearity of anteroposterior decline was determined by a linear regression fit and associated R squared values. ROC curves were calculated to assess the diagnostic performance of these measurements. Data contralateral to the clinically most affected side were used for analysis. Results: ROC curve analysis for differentiation between controls and Parkinsonism patients showed the highest AUC for the caudate nucleus-to-posterior putamen ratio (AUC = 0.930; p < 0.00) and for the R squared value for the linear regression fit (AUC = 0.948; p = 0.006). For discrimating IPD from APD, the highest AUC was found for the caudate nucleus-to-anterior putamen ratio (0.824; p < 0.001) Conclusions: Subregional analysis of the striatum in F-DOPA PET scans may provide additional diagnostic information in patients screened for a  presynaptic dopaminergic deficit. A more linear decrease from the head of the caudate nucleus to the posterior putamen was  present in patients with IPD, although this feature did not have additional diagnostic value over the RSOR analysis. Keywords: PET, Parkinson's disease, Atypical Parkinsonism
first_indexed 2024-12-18T19:43:06Z
format Article
id doaj.art-e9e2893592d74b51a5136cbe3283f8bb
institution Directory Open Access Journal
issn 2213-1582
language English
last_indexed 2024-12-18T19:43:06Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series NeuroImage: Clinical
spelling doaj.art-e9e2893592d74b51a5136cbe3283f8bb2022-12-21T20:55:22ZengElsevierNeuroImage: Clinical2213-15822020-01-0125Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disordersGilles N. Stormezand0Lumi T. Chaves1David Vállez García2Janine Doorduin3Bauke M. De Jong4Klaus L. Leenders5Berry P.H. Kremer6Rudi A.J.O. Dierckx7Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands; Corresponding author.Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, the NetherlandsDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, the NetherlandsDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, the NetherlandsDepartment of Neurology, University of Groningen, University Medical Center Groningen, the NetherlandsDepartment of Neurology, University of Groningen, University Medical Center Groningen, the NetherlandsDepartment of Neurology, University of Groningen, University Medical Center Groningen, the NetherlandsDepartment of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, the NetherlandsAim: L -3,4-dihydroxy-6–18F-fluorophenylalanine (18F-DOPA PET may be used to distinguish subjects with Parkinsonism from those with symptoms not originating from impaired dopaminergic transmission. However, it is not routinely utilized to discriminate Idiopathic Parkinson's disease (IPD) from Atypical Parkinsonian Disorders (APD). We investigated the potential of FDOPA PET to discriminate between IPD and APD, with a focus on the anterior-to-posterior decline in het striatum, considered to be more specific for IPD. Materials and methods: 18F-DOPA PET data from a total of 58 subjects were retrospectively analyzed. 28 subjects had idiopathic Parkinson's disease (14 male, 14 female; age at scan 61 +- 11,5), 13 atypical Parkinsonian disease (7 male, 6 females; age at scan: 69,6 +- 6,4) and 17 were controls (6 male, 11 female; age at scan 65,3 +-8,6). Regional striatal-to-occipital ratio's (RSOR's) were calculated, as well as multiple in-line VOI's from the caudate nucleus to the posterior part of the putamen. The linearity of anteroposterior decline was determined by a linear regression fit and associated R squared values. ROC curves were calculated to assess the diagnostic performance of these measurements. Data contralateral to the clinically most affected side were used for analysis. Results: ROC curve analysis for differentiation between controls and Parkinsonism patients showed the highest AUC for the caudate nucleus-to-posterior putamen ratio (AUC = 0.930; p < 0.00) and for the R squared value for the linear regression fit (AUC = 0.948; p = 0.006). For discrimating IPD from APD, the highest AUC was found for the caudate nucleus-to-anterior putamen ratio (0.824; p < 0.001) Conclusions: Subregional analysis of the striatum in F-DOPA PET scans may provide additional diagnostic information in patients screened for a  presynaptic dopaminergic deficit. A more linear decrease from the head of the caudate nucleus to the posterior putamen was  present in patients with IPD, although this feature did not have additional diagnostic value over the RSOR analysis. Keywords: PET, Parkinson's disease, Atypical Parkinsonismhttp://www.sciencedirect.com/science/article/pii/S2213158219305078
spellingShingle Gilles N. Stormezand
Lumi T. Chaves
David Vállez García
Janine Doorduin
Bauke M. De Jong
Klaus L. Leenders
Berry P.H. Kremer
Rudi A.J.O. Dierckx
Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
NeuroImage: Clinical
title Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
title_full Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
title_fullStr Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
title_full_unstemmed Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
title_short Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
title_sort intrastriatal gradient analyses of 18f fdopa pet scans for differentiation of parkinsonian disorders
url http://www.sciencedirect.com/science/article/pii/S2213158219305078
work_keys_str_mv AT gillesnstormezand intrastriatalgradientanalysesof18ffdopapetscansfordifferentiationofparkinsoniandisorders
AT lumitchaves intrastriatalgradientanalysesof18ffdopapetscansfordifferentiationofparkinsoniandisorders
AT davidvallezgarcia intrastriatalgradientanalysesof18ffdopapetscansfordifferentiationofparkinsoniandisorders
AT janinedoorduin intrastriatalgradientanalysesof18ffdopapetscansfordifferentiationofparkinsoniandisorders
AT baukemdejong intrastriatalgradientanalysesof18ffdopapetscansfordifferentiationofparkinsoniandisorders
AT klauslleenders intrastriatalgradientanalysesof18ffdopapetscansfordifferentiationofparkinsoniandisorders
AT berryphkremer intrastriatalgradientanalysesof18ffdopapetscansfordifferentiationofparkinsoniandisorders
AT rudiajodierckx intrastriatalgradientanalysesof18ffdopapetscansfordifferentiationofparkinsoniandisorders